NCT05634265 is a NA clinical trial of Vijana-SMART in HIV-1-infection, sponsored by University of Washington.

Who is sponsoring NCT05634265?

NCT05634265 is sponsored by University of Washington.

What drugs are being tested in NCT05634265?

Interventions in NCT05634265: Vijana-SMART.

What condition does NCT05634265 study?

NCT05634265 studies HIV-1-infection, Adherence, Medication, Depression.

Is NCT05634265 still recruiting?

NCT05634265 is currently completed. Last updated 2 December 2022.

Last reviewed 2022-12-02 · How we verify

NCT05634265

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study

Completed NA Last updated 2 December 2022

What this trial tests

NA trial testing Vijana-SMART in HIV-1-infection in 55 participants. Completed in 14 December 2019.

Timeline

31 January 2019

Primary endpoint
14 December 2019

14 December 2019

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	55
Start date	31 January 2019
Primary completion	14 December 2019
Estimated completion	14 December 2019
Sites	1 location across Kenya

Drugs / interventions tested

Vijana-SMART

Conditions studied

HIV-1-infection — all drugs for HIV-1-infection →
Adherence, Medication — all drugs for Adherence, Medication →
Depression — all drugs for Depression →

Sponsor

University of Washington

Who can join

Adults 14 to 24, any sex, with HIV-1-infection or Adherence, Medication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to investigate whether a virtual peer support group improves ART knowledge, adherence, and mental health in youth living with HIV in Kenya.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Facilitated WhatsApp Support Groups for Youth Living With HIV in Nairobi, Kenya: Single-Arm Pilot Intervention Study.
Ronen K, Mugo C, Kaggiah A, Seeh D, et al · · 2023 · cited 8× · PMID 37955957 · DOI 10.2196/49174

Verify or expand the search:

Other recruiting trials for HIV-1-infection

Currently open trials in the same condition.

NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT06919016 — A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1- · Phase 1 · active not recruiting
NCT06554717 — Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV · Phase 2 · recruiting
NCT06774872 — Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Succes · Phase 2 · recruiting
NCT06890988 — Ending the Epidemic Interventions in the Dental Setting - UH3 · NA · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05634265 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 2 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05634265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing